{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/CRNX/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-18T15:53:24.195Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9292,"canonical_name":"Crinetics Pharmaceuticals, Inc.","cik":"0001658247","uei":null,"lei":null,"duns":null,"ticker":"CRNX"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":78},"count":78,"timeline":[{"ts":"2026-09-11","kind":"sec.filing","form_type":"15-12G","title":"15-12G — Crinetics Pharmaceuticals, Inc. — 2026-09-11","url_slug":"/sec/cik-0001658247/15-12g/0001140361-26-036281","accession_number":"0001140361-26-036281","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"8-K","title":"8-K — Crinetics Pharmaceuticals, Inc. — 2026-09-01","url_slug":"/sec/cik-0001658247/8-k/0001140361-26-035195","accession_number":"0001140361-26-035195","importance":35},{"ts":"2026-09-01","kind":"sec.filing","form_type":"4","title":"4 — Crinetics Pharmaceuticals, Inc. — 2026-09-01","url_slug":"/sec/cik-0001658247/4/0001628280-26-059882","accession_number":"0001628280-26-059882","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"4","title":"4 — Crinetics Pharmaceuticals, Inc. — 2026-09-01","url_slug":"/sec/cik-0001658247/4/0001628280-26-059883","accession_number":"0001628280-26-059883","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"4","title":"4 — Crinetics Pharmaceuticals, Inc. — 2026-09-01","url_slug":"/sec/cik-0001658247/4/0001628280-26-059884","accession_number":"0001628280-26-059884","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"4","title":"4 — Crinetics Pharmaceuticals, Inc. — 2026-09-01","url_slug":"/sec/cik-0001658247/4/0001628280-26-059885","accession_number":"0001628280-26-059885","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"4","title":"4 — Crinetics Pharmaceuticals, Inc. — 2026-09-01","url_slug":"/sec/cik-0001658247/4/0001628280-26-059901","accession_number":"0001628280-26-059901","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"4","title":"4 — Crinetics Pharmaceuticals, Inc. — 2026-09-01","url_slug":"/sec/cik-0001658247/4/0001628280-26-059904","accession_number":"0001628280-26-059904","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"4","title":"4 — Crinetics Pharmaceuticals, Inc. — 2026-09-01","url_slug":"/sec/cik-0001658247/4/0001628280-26-059905","accession_number":"0001628280-26-059905","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"POSASR","title":"POSASR — Crinetics Pharmaceuticals, Inc. — 2026-09-01","url_slug":"/sec/cik-0001658247/posasr/0001140361-26-035224","accession_number":"0001140361-26-035224","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"POSASR","title":"POSASR — Crinetics Pharmaceuticals, Inc. — 2026-09-01","url_slug":"/sec/cik-0001658247/posasr/0001140361-26-035229","accession_number":"0001140361-26-035229","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Crinetics Pharmaceuticals, Inc. — 2026-09-01","url_slug":"/sec/cik-0001658247/s-8-pos/0001140361-26-035249","accession_number":"0001140361-26-035249","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Crinetics Pharmaceuticals, Inc. — 2026-09-01","url_slug":"/sec/cik-0001658247/s-8-pos/0001140361-26-035250","accession_number":"0001140361-26-035250","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Crinetics Pharmaceuticals, Inc. — 2026-09-01","url_slug":"/sec/cik-0001658247/s-8-pos/0001140361-26-035251","accession_number":"0001140361-26-035251","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Crinetics Pharmaceuticals, Inc. — 2026-09-01","url_slug":"/sec/cik-0001658247/s-8-pos/0001140361-26-035252","accession_number":"0001140361-26-035252","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Crinetics Pharmaceuticals, Inc. — 2026-09-01","url_slug":"/sec/cik-0001658247/s-8-pos/0001140361-26-035253","accession_number":"0001140361-26-035253","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Crinetics Pharmaceuticals, Inc. — 2026-09-01","url_slug":"/sec/cik-0001658247/s-8-pos/0001140361-26-035254","accession_number":"0001140361-26-035254","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Crinetics Pharmaceuticals, Inc. — 2026-09-01","url_slug":"/sec/cik-0001658247/s-8-pos/0001140361-26-035255","accession_number":"0001140361-26-035255","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Crinetics Pharmaceuticals, Inc. — 2026-09-01","url_slug":"/sec/cik-0001658247/s-8-pos/0001140361-26-035256","accession_number":"0001140361-26-035256","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Crinetics Pharmaceuticals, Inc. — 2026-09-01","url_slug":"/sec/cik-0001658247/s-8-pos/0001140361-26-035257","accession_number":"0001140361-26-035257","importance":30},{"ts":"2026-08-28","kind":"sec.filing","form_type":"8-K","title":"8-K — Crinetics Pharmaceuticals, Inc. — 2026-08-28","url_slug":"/sec/cik-0001658247/8-k/0001140361-26-034857","accession_number":"0001140361-26-034857","importance":35},{"ts":"2026-08-24","kind":"sec.filing","form_type":"4","title":"4 — Crinetics Pharmaceuticals, Inc. — 2026-08-24","url_slug":"/sec/cik-0001658247/4/0001628280-26-058664","accession_number":"0001628280-26-058664","importance":30},{"ts":"2026-08-19","kind":"sec.filing","form_type":"8-K","title":"8-K — Crinetics Pharmaceuticals, Inc. — 2026-08-19","url_slug":"/sec/cik-0001658247/8-k/0001140361-26-033738","accession_number":"0001140361-26-033738","importance":35},{"ts":"2026-08-14","kind":"sec.filing","form_type":"8-K","title":"8-K — Crinetics Pharmaceuticals, Inc. — 2026-08-14","url_slug":"/sec/cik-0001658247/8-k/0001140361-26-032951","accession_number":"0001140361-26-032951","importance":35},{"ts":"2026-08-13","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Crinetics Pharmaceuticals, Inc. — 2026-08-13","url_slug":"/sec/cik-0001658247/schedule-13g-a/0000902219-26-000277","accession_number":"0000902219-26-000277","importance":30},{"ts":"2026-08-11","kind":"sec.filing","form_type":"4","title":"4 — Crinetics Pharmaceuticals, Inc. — 2026-08-11","url_slug":"/sec/cik-0001658247/4/0001628280-26-055700","accession_number":"0001628280-26-055700","importance":30},{"ts":"2026-08-07","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Crinetics Pharmaceuticals, Inc. — 2026-08-07","url_slug":"/sec/cik-0001658247/schedule-13g-a/0000315066-26-002233","accession_number":"0000315066-26-002233","importance":30},{"ts":"2026-08-07","kind":"sec.insider.m","reporter":"Struthers Richard Scott","title":"President & CEO","shares":6542,"price_per_share":15.29,"usd_value":100027,"security_title":"Common Stock","importance":15.10002718},{"ts":"2026-08-07","kind":"sec.insider.m","reporter":"Struthers Richard Scott","title":"President & CEO","shares":4995,"price_per_share":20.02,"usd_value":100000,"security_title":"Common Stock","importance":15.0999999},{"ts":"2026-08-07","kind":"sec.insider.m","reporter":"Struthers Richard Scott","title":"President & CEO","shares":4422,"price_per_share":22.61,"usd_value":99981,"security_title":"Common Stock","importance":15.09998142},{"ts":"2026-08-07","kind":"sec.insider.m","reporter":"Struthers Richard Scott","title":"President & CEO","shares":3969,"price_per_share":25.19,"usd_value":99979,"security_title":"Common Stock","importance":15.09997911},{"ts":"2026-08-03","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Crinetics Pharmaceuticals, Inc. — 2026-08-03","url_slug":"/sec/cik-0001658247/10-q/0001658247-26-000053","accession_number":"0001658247-26-000053","importance":45},{"ts":"2026-08-03","kind":"sec.filing","form_type":"8-K","title":"8-K — Crinetics Pharmaceuticals, Inc. — 2026-08-03","url_slug":"/sec/cik-0001658247/8-k/0001658247-26-000052","accession_number":"0001658247-26-000052","importance":35},{"ts":"2026-08-03","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Crinetics Pharmaceuticals, Inc. — 2026-08-03","url_slug":"/sec/cik-0001658247/schedule-13g-a/0000908834-26-000365","accession_number":"0000908834-26-000365","importance":30},{"ts":"2026-07-31","kind":"sec.filing","form_type":"DEFM14A","title":"DEFM14A — Crinetics Pharmaceuticals, Inc. — 2026-07-31","url_slug":"/sec/cik-0001658247/defm14a/0001140361-26-030500","accession_number":"0001140361-26-030500","importance":30},{"ts":"2026-07-21","kind":"sec.filing","form_type":"PREM14A","title":"PREM14A — Crinetics Pharmaceuticals, Inc. — 2026-07-21","url_slug":"/sec/cik-0001658247/prem14a/0001140361-26-029134","accession_number":"0001140361-26-029134","importance":30},{"ts":"2026-07-10","kind":"sec.filing","form_type":"8-K","title":"8-K — Crinetics Pharmaceuticals, Inc. — 2026-07-10","url_slug":"/sec/cik-0001658247/8-k/0001140361-26-028208","accession_number":"0001140361-26-028208","importance":35},{"ts":"2026-07-10","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — Crinetics Pharmaceuticals, Inc. — 2026-07-10","url_slug":"/sec/cik-0001658247/defa14a/0001140361-26-028209","accession_number":"0001140361-26-028209","importance":30},{"ts":"2026-07-06","kind":"sec.filing","form_type":"8-K","title":"8-K — Crinetics Pharmaceuticals, Inc. — 2026-07-06","url_slug":"/sec/cik-0001658247/8-k/0001140361-26-027642","accession_number":"0001140361-26-027642","importance":35},{"ts":"2026-07-06","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — Crinetics Pharmaceuticals, Inc. — 2026-07-06","url_slug":"/sec/cik-0001658247/defa14a/0001140361-26-027643","accession_number":"0001140361-26-027643","importance":30},{"ts":"2026-07-06","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — Crinetics Pharmaceuticals, Inc. — 2026-07-06","url_slug":"/sec/cik-0001658247/defa14a/0001140361-26-027647","accession_number":"0001140361-26-027647","importance":30},{"ts":"2026-07-02","kind":"sec.form144","reporter":"JEFF KNIGHT","title":"Officer","shares":47420,"usd_value":1834206,"security_title":"Common","approx_sale_date":"2026-07-02","accession_number":"0001950047-26-006832","importance":40.36684112},{"ts":"2026-07-02","kind":"sec.form144","reporter":"ROGERIO VIVALDI COELHO","title":"Director","shares":6000,"usd_value":232080,"security_title":"Common","approx_sale_date":"2026-07-02","accession_number":"0001950047-26-006823","importance":40.046416},{"ts":"2026-07-02","kind":"sec.insider.s","reporter":"Vivaldi Coelho Rogerio","title":null,"shares":3000,"price_per_share":40,"usd_value":120000,"security_title":"Common Stock","importance":35.12},{"ts":"2026-07-02","kind":"sec.filing","form_type":"144","title":"144 — Crinetics Pharmaceuticals, Inc. — 2026-07-02","url_slug":"/sec/cik-0001658247/144/0001950047-26-006832","accession_number":"0001950047-26-006832","importance":30},{"ts":"2026-06-22","kind":"sec.filing","form_type":"8-K","title":"8-K — Crinetics Pharmaceuticals, Inc. — 2026-06-22","url_slug":"/sec/cik-0001658247/8-k/0001658247-26-000044","accession_number":"0001658247-26-000044","importance":35},{"ts":"2026-06-22","kind":"sec.filing","form_type":"4","title":"4 — Crinetics Pharmaceuticals, Inc. — 2026-06-22","url_slug":"/sec/cik-0001658247/4/0001628280-26-044708","accession_number":"0001628280-26-044708","importance":30},{"ts":"2026-06-22","kind":"sec.filing","form_type":"4","title":"4 — Crinetics Pharmaceuticals, Inc. — 2026-06-22","url_slug":"/sec/cik-0001658247/4/0001628280-26-044715","accession_number":"0001628280-26-044715","importance":30},{"ts":"2026-06-22","kind":"sec.filing","form_type":"4","title":"4 — Crinetics Pharmaceuticals, Inc. — 2026-06-22","url_slug":"/sec/cik-0001658247/4/0001628280-26-044721","accession_number":"0001628280-26-044721","importance":30},{"ts":"2026-06-18","kind":"sec.filing","form_type":"4","title":"4 — Crinetics Pharmaceuticals, Inc. — 2026-06-18","url_slug":"/sec/cik-0001658247/4/0001628280-26-044419","accession_number":"0001628280-26-044419","importance":30},{"ts":"2026-06-18","kind":"sec.insider.a","reporter":"WIERENGA WENDELL","title":null,"shares":5925,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-18","kind":"sec.insider.a","reporter":"Bedrosian Camille L","title":null,"shares":5925,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-18","kind":"sec.insider.a","reporter":"Fust Matthew K","title":null,"shares":5925,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-18","kind":"sec.insider.a","reporter":"Vivaldi Coelho Rogerio","title":null,"shares":5925,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-18","kind":"sec.insider.a","reporter":"Okey Stephanie","title":null,"shares":5925,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-18","kind":"sec.insider.a","reporter":"Nichols Weston","title":null,"shares":5925,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-18","kind":"sec.insider.a","reporter":"Deardorf Caren","title":null,"shares":5925,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-17","kind":"sec.form144","reporter":"STEPHANIE OKEY","title":"Director","shares":6900,"usd_value":241500,"security_title":"Common","approx_sale_date":"2026-06-17","accession_number":"0001950047-26-006257","importance":40.0483},{"ts":"2026-06-17","kind":"sec.insider.s","reporter":"Okey Stephanie","title":null,"shares":6292,"price_per_share":35.62,"usd_value":224121,"security_title":"Common Stock","importance":35.22412104},{"ts":"2026-06-17","kind":"sec.insider.s","reporter":"Okey Stephanie","title":null,"shares":608,"price_per_share":36.22,"usd_value":22022,"security_title":"Common Stock","importance":35.02202176},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — Crinetics Pharmaceuticals, Inc. — 2026-06-02","url_slug":"/sec/cik-0001658247/4/0001628280-26-039784","accession_number":"0001628280-26-039784","importance":30},{"ts":"2026-05-29","kind":"sec.insider.g","reporter":"Struthers Richard Scott","title":"President & CEO","shares":222200,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.g","reporter":"Struthers Richard Scott","title":"President & CEO","shares":222200,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.g","reporter":"Struthers Richard Scott","title":"President & CEO","shares":80000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.g","reporter":"Struthers Richard Scott","title":"President & CEO","shares":222200,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.g","reporter":"Struthers Richard Scott","title":"President & CEO","shares":222200,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.g","reporter":"Struthers Richard Scott","title":"President & CEO","shares":80000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.g","reporter":"Struthers Richard Scott","title":"President & CEO","shares":111100,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.g","reporter":"Struthers Richard Scott","title":"President & CEO","shares":111100,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.g","reporter":"Struthers Richard Scott","title":"President & CEO","shares":111100,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.g","reporter":"Struthers Richard Scott","title":"President & CEO","shares":111100,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.g","reporter":"Struthers Richard Scott","title":"President & CEO","shares":111100,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.g","reporter":"Struthers Richard Scott","title":"President & CEO","shares":111100,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.g","reporter":"Struthers Richard Scott","title":"President & CEO","shares":111100,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.g","reporter":"Struthers Richard Scott","title":"President & CEO","shares":111100,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Crinetics Pharmaceuticals, Inc. — 2026-05-15","url_slug":"/sec/cik-0001658247/schedule-13g-a/0000080255-26-000423","accession_number":"0000080255-26-000423","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Crinetics Pharmaceuticals, Inc. — 2026-05-15","url_slug":"/sec/cik-0001658247/schedule-13g-a/0000902219-26-000169","accession_number":"0000902219-26-000169","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Crinetics Pharmaceuticals, Inc. — 2026-05-15","url_slug":"/sec/cik-0001658247/schedule-13g-a/0000938206-26-000029","accession_number":"0000938206-26-000029","importance":30}]}